HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dopamine relieves inflammatory responses through the D2 receptor after electroacupuncture at ST36 in a mouse model of chronic obstructive pulmonary disease.

AbstractOBJECTIVE:
To detect the role of dopamine in the anti-inflammatory effect of electroacupuncture (EA) at ST36 in a mouse model of chronic obstructive pulmonary disease (COPD).
METHODS:
Twenty-eight male BALB/c mice were randomly divided into the control group, model group, sham EA (sham) group or ST36 EA (ST36) group in a 1:1:1:1 ratio (n = 7 each). The COPD mouse model was established through cigarette smoke (CS) exposure for 12 weeks. During the last 2 weeks, EA was applied at a sham point location or ST36 before CS exposure. Lung function, histopathological changes, inflammatory cell counts in bronchoalveolar lavage fluid (BALF), inflammatory cytokines in BALF, plasma, lung tissue homogenate (LTH), and plasma dopamine levels were detected in the different groups. Furthermore, the role of different dopamine receptors was explored through intraperitoneal injections of non-specific dopamine receptor antagonist chlorpromazine, specific dopamine D1 receptor antagonist SCH 23390 and specific dopamine D2 receptor antagonist eticlopride hydrochloride prior to ST36 EA and CS exposure.
RESULTS:
EA at ST36 improved lung function, alleviated lung and systemic inflammatory responses by reducing inflammatory cells and cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-8 and IL-1β in BALF, plasma and lung tissue in this COPD mouse model. Plasma dopamine was greatly increased after EA at ST36, negatively correlated with lung histological lesions and inflammatory cytokine levels, and positively correlated with mice body weight and lung function indicators. Chlorpromazine and eticlopride hydrochloride inhibited the anti-inflammatory effect of EA at ST36, while SCH 23390 showed no neutralizing effect.
CONCLUSION:
EA at ST36 could alleviate inflammation in this mouse model of COPD through the dopamine D2 receptor pathway.
AuthorsXuemei Liu, Tao Fan, Jinshuai Guan, Ai Luo, Yan Yu, Daohong Chen, Bing Mao, Hongli Jiang, Wei Liu
JournalAcupuncture in medicine : journal of the British Medical Acupuncture Society (Acupunct Med) Vol. 41 Issue 3 Pg. 163-174 (06 2023) ISSN: 1759-9873 [Electronic] England
PMID35775581 (Publication Type: Journal Article)
Chemical References
  • eticlopride
  • Dopamine
  • Chlorpromazine
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Receptors, Dopamine D2
  • Anti-Inflammatory Agents
Topics
  • Rats
  • Male
  • Mice
  • Animals
  • Electroacupuncture
  • Dopamine
  • Rats, Sprague-Dawley
  • Chlorpromazine
  • Pulmonary Disease, Chronic Obstructive (therapy)
  • Cytokines
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • Disease Models, Animal
  • Receptors, Dopamine D2 (genetics)
  • Anti-Inflammatory Agents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: